AI Science Tracker
EN

Deep Learning Enables 60% Accelerated Volumetric Brain MRI While Preserving Quantitative Performance: A Prospective, Multicenter, Multireader Trial.

Affiliation not stated in the reviewed material · 25 Nov 2021 · medicine

Discovery

Deep Learning Enables 60% Accelerated Volumetric Brain MRI While Preserving Quantitative Performance: A Prospective, Multicenter, Multireader Trial.

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: Primary prospective multicenter/multireader trial: 40 subjects at five institutions/six scanners; vendor-agnostic CNN enhancement of 60%-faster MRI; quantitative volumetrics and clinical disease classification matched standard of care, with blinded readers rating quality. Small sample, industry-affiliated authors and no downstream workflow outcome.

Technology: Primary prospective multicenter/multireader trial: 40 subjects at five institutions/six scanners; vendor-agnostic CNN enhancement of 60%-faster MRI; quantitative volumetrics and clinical disease classification matched standard of care, with blinded readers rating quality. Small sample, industry-affiliated authors and no downstream workflow outcome.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Primary prospective multicenter/multireader trial: 40 subjects at five institutions/six scanners; vendor-agnostic CNN enhancement of 60%-faster MRI; quantitative volumetrics and clinical disease classification matched standard of care, with blinded readers rating quality. Small sample, industry-affiliated authors and no downstream workflow outcome.
Limitation / still unknown
Primary prospective multicenter/multireader trial: 40 subjects at five institutions/six scanners; vendor-agnostic CNN enhancement of 60%-faster MRI; quantitative volumetrics and clinical disease classification matched standard of care, with blinded readers rating quality. Small sample, industry-affiliated authors and no downstream workflow outcome.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC8805755/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.